FCX
50
-2
NDAQ
50
-6
CMI
56
-2
AVGO
88
27
CMS
57
3
LEN
45
3
ORCL
52
-7
WBA
64
4
CRM
72
-3
CCL
68
-2
JBHT
53
-3
EMR
64
-3
YUM
47
-2
RL
75
3
MCO
74
-3
DIS
72
-5
SWKS
53
3
MUR
34
-10
EMC
71
3
PEP
42
-3
FCX
50
-2
NDAQ
50
-6
CMI
56
-2
AVGO
88
27
CMS
57
3
LEN
45
3
ORCL
52
-7
WBA
64
4
CRM
72
-3
CCL
68
-2
JBHT
53
-3
EMR
64
-3
YUM
47
-2
RL
75
3
MCO
74
-3
DIS
72
-5
SWKS
53
3
MUR
34
-10
EMC
71
3
PEP
42
-3
Financhill
Back

Achieve Life Sciences 10K Form

Sell
29

ACHV
Achieve Life Sciences

Last Price:
4.09
Seasonality Move:
12.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACHV News And Ratings

See the #1 stock for the next 7 days that we like better than ACHV

ACHV Financial Statistics

Sales & Book Value

Annual Sales: $5.06M
Cash Flow: $-10.37M
Price / Cash Flow: 0
Annual Sales: $0.91
Price / Book: 4.49

Profitability

EPS (TTM): -1.11000
Net Income (TTM): $-32.94M
Gross Margin: $29.88M
Return on Equity: 0%
Return on Assets: 0%

Achieve Life Sciences Earnings Forecast

Key Achieve Life Sciences Financial Ratios

  • The Gross Profit Margin over the past 17 years for ACHV is 100.00%.
  • The Selling, General & Administrative Expenses for ACHV have been equal to 28.26% of Gross Profit Margin.
  • The Interest Expense is -9.57% of Operating Income.
  • Per Share Earnings over the last 30 years have been positive in 20 years.

Achieve Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACHV
CUSIP: 004468
Website: achievelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACHV Technical Analysis vs Fundamental Analysis

Sell
29
Achieve Life Sciences (ACHV) is a Sell

Is Achieve Life Sciences a Buy or a Sell?